Hans Edgar Bishop Insider Trading $JUNO Juno Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hans Edgar Bishop.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hans Edgar Bishop. Hans Edgar Bishop is in CELGENE CORP /DE/ ($CELG) and Director in AGILENT TECHNOLOGIES INC ($A) and Chief Operating Officer in DENDREON CORP ($DNDN) and CEO & President in Juno Therapeutics, Inc. ($JUNO) and CEO and President in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO) and Director in Sana Biotechnology, Inc. ($SANA).
Hans Edgar Bishop in Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hans Edgar Bishop: CEO & President, CEO and President, See Remarks
Holdings: 184,281 shares
Current Value: $3,825,674
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Hans Edgar Bishop in Juno Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, A, CELG, DNDN, JUNO, SANA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | D | 20.76 | 205,823 | 4,272,885 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | D | 24.50 | 200,000 | 4,900,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | D | 48.06 | 140,000 | 6,728,400 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | D | 6.36 | 451,756 | 2,873,168 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 0.00 | 35,893 | 0 | 0 | 35.9 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 0.00 | 66,426 | 0 | 35,893 | 102.3 K to 35.9 K (-64.92 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 0.00 | 33,133 | 0 | 102,319 | 135.5 K to 102.3 K (-24.46 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 87.00 | 48,829 | 4,248,123 | 135,452 | 184.3 K to 135.5 K (-26.50 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | U | 87.00 | 2,263,948 | 196,963,476 | 184,281 | 2.4 M to 184.3 K (-92.47 %) |
Feb 09 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Gift | G | 0.00 | 116,280 | 0 | 2,448,229 | 2.6 M to 2.4 M (-4.53 %) |
Feb 09 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Payment of Exercise | F | 85.49 | 4,346 | 371,540 | 2,564,509 | 2.6 M to 2.6 M (-0.17 %) |
Feb 02 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Grant | A | 0.00 | 66,426 | 0 | 2,568,855 | 2.5 M to 2.6 M (+2.65 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 245,750 | 1,562,970 | 451,756 | |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 48.56 | 42,457 | 2,061,916 | 2,502,429 | 2.5 M to 2.5 M (-1.67 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 47.69 | 23,003 | 1,097,071 | 2,544,886 | 2.6 M to 2.5 M (-0.90 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 46.52 | 49,082 | 2,283,525 | 2,567,889 | 2.6 M to 2.6 M (-1.88 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 45.53 | 89,888 | 4,092,789 | 2,616,971 | 2.7 M to 2.6 M (-3.32 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 44.72 | 65,820 | 2,943,227 | 2,706,859 | 2.8 M to 2.7 M (-2.37 %) |
Jan 18 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 245,750 | 1,562,970 | 2,772,679 | 2.5 M to 2.8 M (+9.73 %) |
Oct 20 2017 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Grant | A | 0.00 | 35,893 | 0 | 2,526,929 | 2.5 M to 2.5 M (+1.44 %) |
Feb 09 2017 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | A | 20.76 | 205,823 | 4,272,885 | 205,823 | |
Feb 09 2017 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Grant | A | 0.00 | 44,177 | 0 | 2,491,036 | 2.4 M to 2.5 M (+1.81 %) |
Sep 29 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 44,000 | 279,840 | 697,506 | |
Sep 29 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 33.00 | 44,000 | 1,452,000 | 2,446,859 | 2.5 M to 2.4 M (-1.77 %) |
Sep 29 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 44,000 | 279,840 | 2,490,859 | 2.4 M to 2.5 M (+1.80 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 6,057 | 38,523 | 741,506 | |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 6,300 | 40,068 | 747,563 | |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 428 | 2,722 | 753,863 | |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 30.30 | 77,307 | 2,342,588 | 2,446,859 | 2.5 M to 2.4 M (-3.06 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 6,057 | 38,523 | 2,524,166 | 2.5 M to 2.5 M (+0.24 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 30.00 | 6,300 | 189,003 | 2,518,109 | 2.5 M to 2.5 M (-0.25 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 6,300 | 40,068 | 2,524,409 | 2.5 M to 2.5 M (+0.25 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 30.00 | 428 | 12,840 | 2,518,109 | 2.5 M to 2.5 M (-0.02 %) |
Sep 21 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 428 | 2,722 | 2,518,537 | 2.5 M to 2.5 M (+0.02 %) |
Sep 09 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 23,042 | 146,547 | 754,291 | |
Sep 09 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 30.06 | 23,042 | 692,578 | 2,518,109 | 2.5 M to 2.5 M (-0.91 %) |
Sep 09 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 23,042 | 146,547 | 2,541,151 | 2.5 M to 2.5 M (+0.92 %) |
Sep 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 18,173 | 115,580 | 777,333 | |
Sep 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 30.06 | 42,673 | 1,282,554 | 2,518,109 | 2.6 M to 2.5 M (-1.67 %) |
Sep 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 18,173 | 115,580 | 2,560,782 | 2.5 M to 2.6 M (+0.71 %) |
Jul 01 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 44,000 | 279,840 | 795,506 | |
Jul 01 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 39.18 | 6,356 | 249,009 | 2,542,609 | 2.5 M to 2.5 M (-0.25 %) |
Jul 01 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | D | 38.41 | 108,894 | 4,182,107 | 2,548,965 | 2.7 M to 2.5 M (-4.10 %) |
Jul 01 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 44,000 | 279,840 | 2,657,859 | 2.6 M to 2.7 M (+1.68 %) |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Option Exercise | M | 6.36 | 54,000 | 343,440 | 839,506 | |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 48.74 | 5,930 | 289,038 | 2,613,859 | 2.6 M to 2.6 M (-0.23 %) |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 47.97 | 8,394 | 402,674 | 2,619,789 | 2.6 M to 2.6 M (-0.32 %) |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 47.03 | 16,751 | 787,726 | 2,628,183 | 2.6 M to 2.6 M (-0.63 %) |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Sell | S | 45.80 | 59,675 | 2,732,906 | 2,644,934 | 2.7 M to 2.6 M (-2.21 %) |
Jun 13 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Buy | M | 6.36 | 54,000 | 343,440 | 2,704,609 | 2.7 M to 2.7 M (+2.04 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Option Exercise | M | 6.36 | 54,000 | 343,440 | 893,506 | |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Sell | S | 36.46 | 3,879 | 141,421 | 2,650,609 | 2.7 M to 2.7 M (-0.15 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Sell | S | 35.27 | 86,871 | 3,063,584 | 2,654,488 | 2.7 M to 2.7 M (-3.17 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Buy | M | 6.36 | 54,000 | 343,440 | 2,741,359 | 2.7 M to 2.7 M (+2.01 %) |
Feb 04 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Option Exercise | A | 24.50 | 200,000 | 4,900,000 | 200,000 | |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Option Exercise | M | 6.36 | 54,000 | 343,440 | 947,506 | |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Sell | S | 46.64 | 31,255 | 1,457,761 | 2,687,359 | 2.7 M to 2.7 M (-1.15 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Sell | S | 45.73 | 29,404 | 1,344,760 | 2,718,614 | 2.7 M to 2.7 M (-1.07 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Sell | S | 44.77 | 30,841 | 1,380,890 | 2,748,018 | 2.8 M to 2.7 M (-1.11 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO and President | Buy | M | 6.36 | 54,000 | 343,440 | 2,778,859 | 2.7 M to 2.8 M (+1.98 %) |
Mar 05 2015 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Option Exercise | A | 48.06 | 140,000 | 6,728,400 | 140,000 |
Page: 1